ALDR - Alder BioPharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $7.15. This is a potential upside of $7.15 (0%) from yesterday's end of day stock price of $0.

Alder BioPharmaceuticals's activity chart (see below) currently has 53 price targets and 36 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.92% with an average time for these price targets to be met of 79 days.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 16-Sep-2019. First documented stock forecast 02-Jun-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$20

$1.12 (5.93%)

$20

5 years 7 months 22 days ago
(16-Sep-2019)

0/3 (0%)

$1.5 (8.11%)

Buy

$41

5 years 11 months 10 days ago
(28-May-2019)

0/3 (0%)

$21.83 (113.88%)

Buy

$21

$2.12 (11.23%)

$27

6 years 6 days ago
(02-May-2019)

2/11 (18.18%)

$8.76 (71.57%)

155

Buy

$28

$9.12 (48.31%)

$28

6 years 2 months 13 days ago
(25-Feb-2019)

0/5 (0%)

$13.29 (90.35%)

Hold

$15

$-3.88 (-20.55%)

$29

6 years 6 months 26 days ago
(12-Oct-2018)

1/7 (14.29%)

$1.73 (13.04%)

339

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALDR (Alder BioPharmaceuticals) average time for price targets to be met?

On average it took 79 days on average for the stock forecasts to be realized with a an average price target met ratio 18.92

Which analyst has the current highest performing score on ALDR (Alder BioPharmaceuticals) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the current lower performing score on ALDR (Alder BioPharmaceuticals) with a proven track record?

SUMANT KULKARNI

Which analyst has the most public recommendations on ALDR (Alder BioPharmaceuticals)?

Brian Abrahams works at RBC and has 21 price targets and 20 ratings on ALDR

Which analyst is the currently most bullish on ALDR (Alder BioPharmaceuticals)?

Danielle Brill with highest potential upside - $9.12

Which analyst is the currently most reserved on ALDR (Alder BioPharmaceuticals)?

Difei Yang with lowest potential downside - -$3.88

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?